Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Author: Benzinga Insights | March 14, 2023 09:06am

Gainers

  • Ainos (NASDAQ:AIMD) stock increased by 84.7% to $1.33 during Tuesday's pre-market session. The company's market cap stands at $26.6 million.
  • Perspective Therapeutics (AMEX:CATX) shares rose 20.0% to $0.54. The market value of their outstanding shares is at $150.4 million.
  • Amylyx Pharma (NASDAQ:AMLX) stock rose 18.67% to $36.99. The market value of their outstanding shares is at $2.4 billion. As per the press release, Q4 earnings came out yesterday.
  • Navidea Biopharmaceutical (AMEX:NAVB) shares increased by 18.29% to $0.32. The company's market cap stands at $10.3 million.
  • Paratek Pharmaceuticals (NASDAQ:PRTK) stock rose 16.07% to $2.04. The company's market cap stands at $113.4 million.
  • Viracta Therapeutics (NASDAQ:VIRX) stock moved upwards by 15.88% to $1.97. The company's market cap stands at $75.2 million. As per the press release, Q4 earnings came out yesterday.

Losers

  • INVO Bioscience (NASDAQ:INVO) shares fell 23.8% to $0.45 during Tuesday's pre-market session. The company's market cap stands at $5.5 million.
  • China Pharma Holding (AMEX:CPHI) stock decreased by 18.42% to $0.39. The company's market cap stands at $2.0 million.
  • OKYO Pharma (NASDAQ:OKYO) stock declined by 16.59% to $1.76. The market value of their outstanding shares is at $38.3 million.
  • Axogen (NASDAQ:AXGN) stock fell 12.36% to $6.6. The market value of their outstanding shares is at $279.0 million. The company's, Q4 earnings came out today.
  • Gelesis Holdings (NYSE:GLS) stock fell 12.17% to $0.2. The company's market cap stands at $14.6 million.
  • Cingulate (NASDAQ:CING) stock decreased by 12.13% to $1.16. The market value of their outstanding shares is at $13.1 million. The company's, Q4 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AIMD AMLX AXGN CATX CING CPHI GLS INVO NAVB OKYO PRTK VIRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist